To accelerate and expand its efforts, crispr therapeutics has formed strategic partnerships with leading companies including vertex pharmaceuticals. Crispr/cas9 is a revolutionary technology that allows for precise, directed changes to genomic dna Crispr/cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic dna The company has established a portfolio oftherapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology and rare diseases.
WATCH
